The University of Chicago Header Logo

Connection

Jennifer Cooperrider to Myelodysplastic Syndromes

Back to Details
This is a "connection" page, showing publications Jennifer Cooperrider has written about Myelodysplastic Syndromes.
Jennifer Cooperrider
Connection Strength
0.521
Myelodysplastic Syndromes
  1. Phase I trial of maintenance selinexor after allogeneic hematopoietic stem cell transplantation for patients with acute myeloid leukemia and myelodysplastic syndrome. Bone Marrow Transplant. 2020 11; 55(11):2204-2206.
    View in: PubMed
    Score: 0.521
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.